Second Affiliated Hospital, School Of Medicine, Zhejiang University
Clinical trials sponsored by Second Affiliated Hospital, School Of Medicine, Zhejiang University, explained in plain language.
-
Wart war: Head-to-Head injection battle on Patients' own feet
Disease control Not yet recruitingThis study compares two different injections (bleomycin and pingyangmycin) for treating stubborn plantar warts on feet. Each participant serves as their own control—one wart gets one injection, another wart gets the other injection. Researchers will track which treatment works be…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 21:40 UTC
-
Can a simple diet change slow down memory loss?
Disease control Not yet recruitingThis study is testing whether eating foods high in resistant starch can help slow down memory and thinking problems in adults who are at high genetic risk for cognitive decline. It will involve 70 overweight adults aged 40 and over. Participants will be randomly assigned to eat e…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Gut bacteria joins fight against advanced cancers
Disease control Not yet recruitingThis study is testing if adding a specific probiotic (Lactobacillus johnsonii) to standard chemotherapy and immunotherapy helps people with certain advanced cancers. It will enroll 156 adults with advanced lung, breast, or stomach cancer that has stopped responding to prior immun…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New pill tested to stop liver Cancer's return after surgery
Disease control Not yet recruitingThis study is testing whether a capsule called icaritin can help prevent liver cancer from returning after surgery in patients at high risk for recurrence. It will involve 25 patients who have had a liver tumor removed. The goal is to see if taking this medication after surgery c…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New Four-Pronged attack on advanced liver cancer enters testing
Disease control Not yet recruitingThis study is testing a combination of four treatments for advanced liver cancer that cannot be removed by surgery. It aims to see if adding a new drug (ipilimumab N01) to a standard three-part regimen is safe and more effective. Researchers will enroll 36 adults and compare thre…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Three-Drug attack on tough ovarian cancers
Disease control Not yet recruitingThis study is testing whether a combination of three drugs—benmelstobart, anlotinib, and cyclophosphamide—can help control recurrent ovarian, fallopian tube, or primary peritoneal cancer. It will enroll 40 participants in China who have seen their cancer return after previous tre…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Stem cell shot aims to heal torn shoulder tendons
Disease control Not yet recruitingThis early-stage study is testing whether injecting tendon stem cells during shoulder surgery can help heal rotator cuff tears better than surgery alone. The goal is to see if this cell therapy is safe and if it improves shoulder strength, movement, and reduces pain for patients.…
Phase: EARLY_PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New cell shot tested for patients with untreatable bowel disease
Disease control Not yet recruitingThis early-stage study is testing a new cell injection called CNK-UT009 in patients with severe inflammatory bowel disease (Crohn's or colitis) that hasn't improved with standard treatments. The main goals are to check if the treatment is safe and to find the right dose. Research…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New shot at fighting rare cancer: experimental combo therapy trial opens
Disease control Not yet recruitingThis study is testing whether adding a new immunotherapy drug called envafolimab to standard chemotherapy works better for advanced soft tissue sarcoma. The trial will involve about 15 adults with this rare cancer who haven't had any prior treatment. Researchers hope the combinat…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
AI steps into the ER to speed up stroke care
Disease control Not yet recruitingThis study is testing a new AI computer system called LingBao, designed to help doctors quickly decide the best treatment for patients having a stroke. At 20 major stroke centers, half will use the AI system alongside standard care, while the other half will use standard care alo…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New Two-Pronged drug tested to shrink tumors before esophageal cancer surgery
Disease control Not yet recruitingThis study is testing a new drug called Ivonescimab, given with standard chemotherapy, to patients with a type of esophageal cancer before they have surgery. The goal is to see if this combination can shrink the tumor more effectively and reduce the chance of the cancer coming ba…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New drug combo tested to unclog hearts after major attack
Disease control Not yet recruitingThis study is testing if adding the blood thinner rivaroxaban to standard medications improves blood flow in the heart's arteries after a procedure to open a blockage from a severe heart attack. Researchers will compare the new three-drug combination to the standard two-drug ther…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New endoscopic approach aims to help Crohn's patients avoid surgery
Disease control Not yet recruitingThis study compares two minimally invasive endoscopic procedures for treating small intestinal narrowing (strictures) in people with Crohn's disease. Researchers want to see which method—balloon dilation or a small incision technique—is more effective at keeping the passage open …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Light vs. scalpel: new study tests gentler treatment for cervical lesions
Disease control Not yet recruitingThis study aims to see if a light-based therapy called ALA-PDT works as well as standard surgery (LEEP) for treating high-grade cervical cell changes (HSIL/CIN2). It will involve 560 women aged 25-60. The goal is to find a less invasive treatment option that may better preserve c…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Brain cell transplant tested as new hope for untreatable epilepsy
Disease control Not yet recruitingThis early study is testing a new cell therapy for adults with severe epilepsy that doesn't respond to medications. Doctors will inject specially grown brain cells directly into the brain during surgery, and patients will take immune-suppressing drugs before and after. The main g…
Phase: EARLY_PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New approach aims to keep breast cancer treatment on track by protecting blood cells
Disease control Not yet recruitingThis study is testing whether a drug called leucogen can prevent a serious side effect of breast cancer treatment. Researchers want to see if leucogen reduces severe drops in white blood cells (neutropenia) in early-stage breast cancer patients taking ribociclib with hormone ther…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Light beam targets HPV before it turns into cancer
Disease control Not yet recruitingThis study is testing whether a light-based treatment can clear high-risk HPV infection and reverse early abnormal cervical cell changes. It will compare the treatment to simply watching and waiting in 225 women aged 20-60 who have HPV types 16 or 18. The goal is to see if the tr…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Brain scan study aims to personalize Alzheimer's treatment
Disease control Not yet recruitingThis study is testing whether the antibody drug lecanemab helps control Alzheimer's disease progression better than standard treatments. Researchers will follow 120 patients with early Alzheimer's or mild cognitive impairment to see who benefits most from continued treatment. Usi…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Fertility Face-Off: which treatment delivers more babies?
Disease control Not yet recruitingThis study aims to find out which of two common fertility treatments works better for couples who can't get pregnant but have no clear medical reason why. It will follow 848 couples in China undergoing their first treatment cycle, randomly assigning them to either standard IVF or…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Engineered 'Smart Cells' target deadly lung scarring in pioneering trial
Disease control Not yet recruitingThis early-stage trial is testing a new cell therapy for people with severe, end-stage idiopathic pulmonary fibrosis (IPF), a fatal lung-scarring disease. Doctors will give patients specially engineered immune cells designed to find and calm the scar tissue in the lungs. The main…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for Tough-to-Treat colon cancer patients
Disease control Not yet recruitingThis study is testing whether the drug everolimus can help control advanced colorectal cancer that has a specific genetic change called CDK12 deficiency and has stopped responding to standard treatments. The trial will first find the safest dose, then see if the drug shrinks tumo…
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New pain drug tested on seniors after surgery
Disease control Not yet recruitingThis study aims to understand how a new pain medication called Anrikefon is processed in the bodies of older adults after abdominal surgery. It will enroll 30 participants aged 65 and older to measure the drug's levels in their blood. The goal is to gather information to help det…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Your own wisdom tooth could save your smile: study seeks best method
Disease control Not yet recruitingThis study aims to find the best way to manage the nerve inside a tooth when a healthy wisdom tooth is transplanted to replace a bad molar. Researchers will compare three different nerve care strategies in 360 participants to see which leads to the most successful, long-lasting t…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New heart drug tested in Real-World patients
Disease control Not yet recruitingThis study aims to see how well the drug mavacamten works for people with a specific form of hypertrophic cardiomyopathy (HCM), where the heart muscle is abnormally thick and causes a blockage in the middle or tip of the heart's main pumping chamber. It will involve 132 adult pat…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Three-Pronged attack on tough colon cancers before surgery
Disease control Not yet recruitingThis study is testing a new three-drug combination given before surgery for locally advanced colorectal cancer. The goal is to see if adding an immunotherapy drug and a diabetes drug (sitagliptin) to standard chemotherapy can shrink tumors more effectively. The trial will first c…
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Breakthrough mouthwash forms protective shield against gum disease
Disease control Not yet recruitingThis study is testing whether a new type of mouthwash called Amphion can help people with gum disease when used alongside standard dental cleaning treatments. The mouthwash works by forming a protective barrier in the mouth to prevent plaque from regrowing, potentially reducing i…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Herbal remedy tested to stop chronic cough from coming back
Disease control Not yet recruitingThis study is testing if adding a traditional Chinese herbal formula called Liqin Zhike to standard asthma inhalers works better for a type of asthma that mainly causes a long-lasting cough. Researchers will compare two groups of 118 adults each over 14 months to see which treatm…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New pill could reduce need for steroids in painful muscle condition
Disease control Not yet recruitingThis study is testing whether an oral medication called ivarmacitinib can help control polymyalgia rheumatica (PMR) while reducing the need for steroid medications. The trial will involve 80 adults aged 50-75 with active PMR who will receive either the study drug or a placebo for…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for Tough-to-Treat sarcoma? trial tests aggressive drug combo
Disease control Not yet recruitingThis study is testing a new combination of three existing drugs to see if it can help control advanced soft tissue sarcoma that has come back or stopped responding to other treatments. It will involve 24 patients who have already tried at least one prior therapy. The main goals a…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Scientists test supercharged immune cells against deadly brain cancer
Disease control Not yet recruitingThis early-stage study is testing a new type of cell therapy for adults with glioblastoma that has come back after treatment. Doctors will collect a patient's own immune cells, modify them in a lab to better target the cancer, and then infuse them back. The main goals are to see …
Phase: EARLY_PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
First-in-Human trial: engineered immune cells battle deadly heart shock
Disease control Not yet recruitingThis early-stage study is testing a new cell therapy for people who have a severe heart attack that leads to cardiogenic shock, a dangerous condition where the heart can't pump enough blood. Researchers are giving patients specially engineered immune cells from healthy donors, de…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
Blood filter tested to stop stroke swelling
Disease control Not yet recruitingThis study is testing if a device called Adacolumn can help control dangerous brain swelling that can happen after a major stroke. It will involve 10 patients who have already had a procedure to remove the stroke-causing clot. Half will get the device treatment, which filters cer…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
Which surgery works better for overweight colon cancer patients?
Disease control Not yet recruitingThis study aims to determine whether traditional open surgery or minimally invasive laparoscopic surgery leads to better long-term outcomes for colon cancer patients who have significant abdominal fat. Researchers will follow 664 patients for five years after surgery to see which…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC
-
New drug trial aims to stop aggressive cancer from coming back
Disease control Not yet recruitingThis study is testing if a drug called surufatinib can help prevent cancer from returning after surgery in patients with high-risk neuroendocrine tumors. It will enroll about 35 patients whose cancer is classified as Stage III or has other high-risk features. The main goal is to …
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC
-
New hope for debilitating dizziness? study tests migraine drugs
Disease control Not yet recruitingThis study aims to see how well a newer class of migraine drugs (CGRP-targeted medications) works for treating vestibular migraine, a condition that causes severe dizziness and vertigo. It will follow 2,000 Chinese patients in a real-world setting to measure if these drugs can re…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC
-
Less thyroid surgery, same cancer control? major trial aims to find out
Disease control Not yet recruitingThis study aims to determine if a smaller, more conservative surgery is as effective as complete thyroid removal for treating certain low-risk thyroid cancers located in the middle of the gland. It will involve 520 adults with small, unspread tumors and directly compare cancer re…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
AI Doctor's assistant aims to spot hidden diseases in scans
Diagnosis Not yet recruitingThis study is testing a new artificial intelligence (AI) system designed to help doctors diagnose diseases of the liver, gallbladder, and pancreas. The AI will analyze patients' medical scans (like CT or MRI) along with their health records to see if it can identify diseases and …
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Mar 31, 2026 12:12 UTC
-
AI breakthrough could spot breast cancer early without risky dye
Diagnosis Not yet recruitingThis study aims to develop an artificial intelligence (AI) tool that can detect breast cancer early using standard MRI scans without contrast dye. It will enroll 30,000 women in China to test if this safer, more accessible method is as accurate as current techniques. The goal is …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Mar 30, 2026 14:33 UTC
-
AI scans tissue slides to predict which liver cancer treatments will work
Diagnosis Not yet recruitingThis study is developing an artificial intelligence (AI) tool to help doctors choose the best treatment for patients after liver cancer surgery. The AI analyzes standard digital images of a patient's tumor tissue to predict whether they are likely to benefit from specific follow-…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC
-
AI model aims to predict your next heart attack
Diagnosis Not yet recruitingThis study aims to develop and test an artificial intelligence (AI) tool designed to predict a patient's risk of having another heart attack within six months. It will enroll 1,500 adults who have just had a heart attack and received a stent. The AI model will analyze a wide rang…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Mar 27, 2026 12:41 UTC
-
AI blood test aims to pinpoint breast cancer spread
Diagnosis Not yet recruitingThis study is testing a new AI-powered blood test to see how accurately it can determine the stage of breast cancer, specifically whether it has spread to lymph nodes. Researchers will collect blood samples from 269 people with breast cancer, some having surgery directly and othe…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Mar 24, 2026 12:03 UTC
-
AI eyes your heart: can a scan spot hidden valve trouble?
Diagnosis Not yet recruitingThis study aims to test a new artificial intelligence (AI) tool designed to screen for heart valve disease. It will analyze routine chest CT scans from 10,000 people to see if the AI can accurately identify those with moderate-to-severe valve problems. If the AI flags a potential…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Mar 13, 2026 15:06 UTC
-
Study tests which anesthesia gets you home faster after ankle surgery
Symptom relief Not yet recruitingThis study compares three different anesthesia approaches for people having minimally invasive ankle surgery. Researchers want to see which method helps patients wake up faster after surgery, experience less pain and nausea, and go home sooner. The trial will involve 200 adults h…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Apr 03, 2026 14:45 UTC
-
Could a single shot ease days of Post-Surgery pain?
Symptom relief Not yet recruitingThis study is testing a new, long-acting numbing medicine (liposomal bupivacaine) to see if it can better control pain after a specific brain surgery called microvascular decompression. Researchers will inject the medicine directly into the surgical site in half of the 100 partic…
Phase: EARLY_PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Apr 03, 2026 14:43 UTC
-
Zapping anxiety away? ear device trial aims to calm surgery patients
Symptom relief Not yet recruitingThis study is testing whether a gentle, non-invasive electrical stimulation device placed on the ear can help reduce anxiety in patients before and after major abdominal surgery. Researchers will compare the real device to a fake one in 282 patients to see if it lowers anxiety, i…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Zapping the ear to ease back surgery pain?
Symptom relief Not yet recruitingThis study tests whether gentle electrical stimulation on the ear can help reduce pain and the need for strong painkillers after complex spine surgery. Researchers will enroll 98 patients having major spinal operations. Participants will be randomly assigned to receive either rea…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 30, 2026 14:35 UTC
-
High-Tech hope for Post-Stroke depression: VR therapy meets brain stimulation
Symptom relief Not yet recruitingThis study aims to see if a high-tech combination treatment can help ease depression that occurs after a stroke. Researchers will test whether using virtual reality mindfulness therapy together with a gentle, non-invasive brain stimulation technique works better than either treat…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 30, 2026 14:31 UTC
-
Clearer view for ankle surgery? study tests alternative to tourniquet
Symptom relief Not yet recruitingThis study compares two methods to help surgeons see better during ankle surgery. One group gets a special irrigation fluid containing epinephrine, while the other gets the standard tourniquet. Researchers will measure how clear the surgical view is and check patients' pain level…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 23, 2026 15:19 UTC
-
Healing ankle sprains in a pressure chamber?
Symptom relief Not yet recruitingThis study is testing whether breathing pure oxygen in a pressurized chamber helps people with recent ankle sprains recover faster. It will compare this special oxygen treatment against breathing normal air to see which one better reduces pain and swelling and improves ankle func…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 10, 2026 12:53 UTC
-
Zapping the brain with needles: can ancient practice fix stroke memory loss?
Symptom relief Not yet recruitingThis study is testing whether electroacupuncture (a combination of acupuncture with mild electrical stimulation) can help improve thinking and memory in people who have cognitive problems after a stroke. About 110 participants will be randomly assigned to receive either real elec…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 09, 2026 14:23 UTC
-
AI model aims to predict future heart trouble after a heart attack
Knowledge-focused Not yet recruitingThis study aims to create a better tool to predict which heart attack survivors are at highest risk for having another serious heart problem. Researchers will collect detailed health data from over 1,500 people who have had a heart attack and undergone a stent procedure. They wil…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Apr 03, 2026 21:40 UTC
-
Tracking 500 patients to unlock secrets of sports injury recovery
Knowledge-focused Not yet recruitingThis study aims to understand why recovery varies so much after common minimally invasive surgeries for sports injuries like ligament tears and rotator cuff damage. Researchers will follow 500 patients for two years after their scheduled shoulder or knee surgery, collecting detai…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC
-
Cleaner skin before surgery? study tests methods to cut infection risk
Knowledge-focused Not yet recruitingThis study aims to find out which of two standard methods for cleaning and removing hair from the skin before surgery is better at reducing bacteria. It will involve 40 men scheduled for a specific type of urethral stricture repair surgery. Researchers will measure the amount and…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
Scientists building cancer sample library for future breakthroughs
Knowledge-focused Not yet recruitingThis study aims to create a collection of tissue and blood samples from patients with liver, bile duct, and pancreatic cancers. Researchers will collect leftover samples from routine medical care without any additional procedures for participants. The collection will serve as a r…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Massive study probes how ERs manage patient pain and sedation
Knowledge-focused Not yet recruitingThis study aims to understand how emergency room staff in China manage patient pain and sedation. It will survey thousands of healthcare workers and observe patient care to see if standard guidelines are being followed. The goal is to identify gaps in knowledge and practice to im…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
New ventilator put to the test for safer patient transport
Knowledge-focused Not yet recruitingThis study aims to compare a new emergency transport ventilator to a standard one to see if it keeps oxygen levels just as stable when moving patients who are on breathing machines. Researchers will enroll about 98 adults who need to be moved within or between hospitals while on …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
AI eye scan could predict your injection future
Knowledge-focused Not yet recruitingThis study aims to use artificial intelligence (AI) to analyze special eye scans (OCTA) from 110 patients. The goal is to find patterns that can predict how well standard eye injections work over two years for a condition called myopic choroidal neovascularization (mCNV), which c…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC
-
Prospective, randomized, multicenter clinical trial of bisphosphonates bombined with vancomycin for the treatment of Cierny-Mader type i and III osteomyelitis
Not yet recruitingA Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Efficacy and Safety of Bisphosphonates Combined with Vancomycin in the Treatment of Refractory Osteomyelitis
Phase: PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Last updated Mar 02, 2026 15:25 UTC